osimertinib
astrazeneca
['adaura', 'nsclc', 'sclc', 'aura ,(-laura)', 'astrazeneca']
we re unveiling adaura phase iii trial data at #esmo22. the data continues to show progress in improving efgrm nsclc patient outcomes, including improving cns dfs. 
The official Twitter feed for AstraZeneca US. For more info visit http://t.co/5VlUaVGyiC.